|

IDE574 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • IDEAYA Biosciences1

Indications

  • Microsatellite Stable (MSS) Colorectal Carcinoma1
  • ER+, HER 2- Breast Cancer1
  • Castration-Resistant Prostate Cancer (CRPC)1
  • Non-small Cell Lung Cancer (NSCLC)1
  • Lung Cancer1

Lake Success, New York1 trial

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

START NY

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.